Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Recent Developments In February 2026 , Pfizer announced positive Phase 2b trial results for its ultra-long-acting injectable GLP-1 (PF-08653944), demonstrating significant weight loss with monthly dosing
Furthermore, other studies have demonstrated the impact of efferocytosis on DCs maturation, significantly reducing the expression of costimulatory molecules and MHC-II [39]
In addition, IGF-1 LR3 may promote fat breakdown by activating the MAPK pathway, leading to increased levels of free fatty acids and further exacerbating insulin resistance, forming a vicious cycle
Although L-Carnitine can be produced by the body itself, it is only produced in small amounts
